Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Drugs in Development
Details:
Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Achondroplasia.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Genetic Disease Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Hormone
Sponsor: Children's Hospital of Fudan University | Tongji Hospital | Children's Hospital of Nanjing Medical University | Jiangxi Province Children's Hospital | Chengdu Women's and Children's Central Hospital | Shandong Provincial Hospital | Shengjing Hospital | Sh
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable April 29, 2022
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Genetic Disease
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Children's Hospital of Fudan University | Tongji Hospital | Children's Hospital of Nanjing Medical University | Jiangxi Province Children's Hospital | Chengdu Women's and Children's Central Hospital | Shandong Provincial Hospital | Shengjing Hospital | Sh
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Achondroplasia.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
April 29, 2022
Details:
Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Prader-Willi Syndrome.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Genetic Disease Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Hormone
Sponsor: Children's Hospital of Fudan University | Tongji Medical College, Huazhong University of Science and Technology | Beijing Children's Hospital | Peking University First Hospital | Peking Union Medical College Hospital | The Children's Hospital of Zhejiang
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 12, 2018
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Genetic Disease
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Children's Hospital of Fudan University | Tongji Medical College, Huazhong University of Science and Technology | Beijing Children's Hospital | Peking University First Hospital | Peking Union Medical College Hospital | The Children's Hospital of Zhejiang
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Prader-Willi Syndrome.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
June 12, 2018
Details:
Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Dwarfism.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Genetic Disease Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Hormone
Sponsor: Children's Hospital of Fudan University | Beijing Children's Hospital | Shanghai Children's Hospital | Xin Hua Hospital, Shanghai Jiaotong University School of Medicine | The Children's Hospital of Zhejiang University School of Medicine | Children's Hospi
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 24, 2018
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Genetic Disease
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Children's Hospital of Fudan University | Beijing Children's Hospital | Shanghai Children's Hospital | Xin Hua Hospital, Shanghai Jiaotong University School of Medicine | The Children's Hospital of Zhejiang University School of Medicine | Children's Hospi
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Dwarfism.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
May 24, 2018
Details:
Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IIIProduct Type: Hormone
Sponsor: Tongji Hospital | Beijing Children's Hospital | The First Affiliated Hospital with Nanjing Medical University | Shanghai Children's Hospital | The Children's Hospital of Zhejiang University School of Medicine
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable August 10, 2017
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase III
Partner/Sponsor/Collaborator : Tongji Hospital | Beijing Children's Hospital | The First Affiliated Hospital with Nanjing Medical University | Shanghai Children's Hospital | The Children's Hospital of Zhejiang University School of Medicine
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
August 10, 2017
Details:
Somatotropin is a Hormone drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of HIV Infections.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Infections and Infectious Diseases Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Hormone
Sponsor: EMD Serono
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable March 27, 2017
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : EMD Serono
Deal Size : Inapplicable
Deal Type : Inapplicable
Impact of Recombinant Human Growth Hormone on HIV Persistence
Details : Somatotropin is a Hormone drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of HIV Infections.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
March 27, 2017
Details:
Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in clinical studies for the treatment of Polycystic Ovary Syndrome.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Hormone
Sponsor: Peking University Third Hospital
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 16, 2016
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Peking University Third Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in clinical studies for the treatment of Polycystic Ovary Syndrome.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
June 16, 2016
Details:
Genotropin is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Undisclosed Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Protein
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 22, 2013
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Undisclosed
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Long Term Study of Genotropin (Somatropin) for Short Children Born Small for Gestational Age (SGA)
Details : Genotropin is a Protein drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Protein
Upfront Cash : Inapplicable
May 22, 2013
Details:
Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dwarfism, Pituitary.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Endocrinology Brand Name: Undisclosed
Study Phase: Phase IVProduct Type: Hormone
Sponsor: Undisclosed
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable May 24, 2012
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Phase IV
Partner/Sponsor/Collaborator : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Efficacy of SR-hGH (Sustained-release Human Growth Hormone, Declage Inj.)
Details : Recombinant Human Growth Hormone is a Hormone drug candidate, which is currently being evaluated in phase IV clinical studies for the treatment of Dwarfism, Pituitary.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
May 24, 2012
Details:
Somatotropin is a Hormone drug candidate, which is currently being evaluated in clinical studies for the treatment of Turner Syndrome.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Endocrinology Brand Name: Undisclosed
Study Phase: UndisclosedProduct Type: Hormone
Sponsor: Rebecca Knickmeyer Santelli, PhD
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable June 07, 2011
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Endocrinology
Highest Development Status : Undisclosed
Partner/Sponsor/Collaborator : Rebecca Knickmeyer Santelli, PhD
Deal Size : Inapplicable
Deal Type : Inapplicable
Effect of Growth Hormone on Early Brain Development in Girls With Turner Syndrome
Details : Somatotropin is a Hormone drug candidate, which is currently being evaluated in clinical studies for the treatment of Turner Syndrome.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
June 07, 2011
Details:
Somatotropin is a Hormone drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Infertility.
Lead Product(s): Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area: Obstetrics/Gynecology (Women’s Health) Brand Name: Undisclosed
Study Phase: Phase IIProduct Type: Hormone
Sponsor: EMD Serono
Deal Size: Inapplicable Upfront Cash: Inapplicable
Deal Type: Inapplicable September 17, 2010
Lead Product(s) : Recombinant Human Growth Hormone,Inapplicable
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase II
Partner/Sponsor/Collaborator : EMD Serono
Deal Size : Inapplicable
Deal Type : Inapplicable
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)
Details : Somatotropin is a Hormone drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Infertility.
Product Name : Undisclosed
Product Type : Hormone
Upfront Cash : Inapplicable
September 17, 2010
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
ABOUT THIS PAGE
